These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30655699)

  • 1. Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan.
    Asghar K; Loya A; Rana IA; Tahseen M; Ishaq M; Farooq A; Bakar MA; Masood I
    Cancer Manag Res; 2019; 11():475-481. PubMed ID: 30655699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan.
    Asghar K; Loya A; Rana IA; Abu Bakar M; Farooq A; Tahseen M; Ishaq M; Rashid MU
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3521-3525. PubMed ID: 31759380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients.
    Asghar K; Loya A; Rana IA; Bakar MA; Farooq A; Tahseen M; Ishaq M; Masood I; Rashid MU
    World J Clin Oncol; 2020 Dec; 11(12):1018-1028. PubMed ID: 33437664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytotoxic effects of indoleamine 2, 3-dioxygenase inhibitors on triple negative breast cancer cells upon tumor necrosis factor α stimulation.
    Bilir C; Eskiler GG; Bilir F
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S74-S80. PubMed ID: 37147986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1 is Fascinating but IDO Needs Attention in Non-HCV and Non-HBV-Associated Hepatocellular Carcinoma Patients.
    Asghar K; Bashir S; Ali Rana I; Abu Bakar M; Farooq A; Hassan M; Asif Z; Afzal M; Masood I; Ishaq M; Tahseen M; Bilal S; Mehmood S; Kanwal N; Ud Din I; Loya A
    J Hepatocell Carcinoma; 2023; 10():921-934. PubMed ID: 37350801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry.
    Soliman H; Rawal B; Fulp J; Lee JH; Lopez A; Bui MM; Khalil F; Antonia S; Yfantis HG; Lee DH; Dorsey TH; Ambs S
    Cancer Immunol Immunother; 2013 May; 62(5):829-37. PubMed ID: 23344392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of immune checkpoints (PD-L1 and IDO) and tumour-infiltrating lymphocytes in breast cancer.
    Alkhayyal N; Elemam NM; Hussein A; Magdub S; Jundi M; Maghazachi AA; Talaat IM; Bendardaf R
    Heliyon; 2022 Sep; 8(9):e10482. PubMed ID: 36097493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G.
    Jing R; Bai S; Zhang P; Ren H; Jia L; Li W; Zheng G
    Breast Cancer; 2024 Jan; 31(1):135-147. PubMed ID: 37981615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer.
    Zhao Y; Wei L; Liu J; Li F
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):77-93. PubMed ID: 31844921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis significance of indoleamine 2, 3-dioxygenase, programmed death ligand-1 and tumor-infiltrating immune cells in microenvironment of breast cancer.
    Wei L; Wu N; Wei F; Li F; Zhang Y; Liu J; Ren X
    Int Immunopharmacol; 2020 Jul; 84():106506. PubMed ID: 32330866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of indoleamine 2-3 dioxygenase (IDO) and EGFR co-expression in breast cancer tissue by immunohistochemistry.
    Bi WW; Zhang WH; Yin GH; Luo H; Wang SQ; Wang H; Li C; Yan WQ; Nie DZ
    Asian Pac J Cancer Prev; 2014; 15(14):5535-8. PubMed ID: 25081660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients.
    Asghar K; Rana IA; Abubakar M; Hasham K; Tahseen M; Bilal S; Mehmood S; Farooq A; Siddique K; Loya A
    Asian Pac J Cancer Prev; 2023 May; 24(5):1591-1600. PubMed ID: 37247278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
    Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
    Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer.
    Uzelac B; Krivokuca A; Brankovic-Magic M; Magic Z; Susnjar S; Milovanovic Z; Supic G
    Pathol Oncol Res; 2020 Oct; 26(4):2723-2731. PubMed ID: 32681437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoleamine-2,3-dioxygenase and Interleukin-6 associated with tumor response to neoadjuvant chemotherapy in breast cancer.
    Li F; Wei L; Li S; Liu J
    Oncotarget; 2017 Dec; 8(64):107844-107858. PubMed ID: 29296206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment and in tumor-draining lymph nodes of breast cancer.
    Ye Q; Wang C; Xian J; Zhang M; Cao Y; Cao Y
    Hum Pathol; 2018 May; 75():81-90. PubMed ID: 29447919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer.
    Wei L; Zhu S; Li M; Li F; Wei F; Liu J; Ren X
    Front Immunol; 2018; 9():724. PubMed ID: 29719533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological Study of Triple-Negative Breast Cancer Patients in North Indian Population: a Hospital-Based Study.
    Gupta M; Khanna S; Kumar M; Kar AG; Gupta SK
    Indian J Surg Oncol; 2017 Sep; 8(3):279-283. PubMed ID: 36118385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy.
    Inaba T; Ino K; Kajiyama H; Shibata K; Yamamoto E; Kondo S; Umezu T; Nawa A; Takikawa O; Kikkawa F
    Gynecol Oncol; 2010 Jun; 117(3):423-8. PubMed ID: 20350764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.